Enanta Pharmaceuticals, Inc.
ENTA · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$82 | -$116 | -$134 | -$122 |
| Dep. & Amort. | $5 | $2 | $2 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $19 | $27 | $28 | $27 |
| Change in WC | -$2 | $7 | $8 | $7 |
| Other Non-Cash | $41 | $1 | -$8 | $0 |
| Operating Cash Flow | -$19 | -$79 | -$103 | -$85 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$18 | -$9 | -$2 |
| Net Acquisitions | $0 | $0 | $45 | -$55 |
| Inv. Purchases | -$210 | -$307 | -$373 | -$171 |
| Inv. Sales/Matur. | $263 | $383 | $329 | $228 |
| Other Inv. Act. | $0 | $0 | -$45 | $55 |
| Investing Cash Flow | $40 | $58 | -$54 | $55 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$27 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$27 | -$0 | $198 | $20 |
| Financing Cash Flow | -$27 | -$28 | $198 | $20 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | -$48 | $41 | -$10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41 | $89 | $48 | $58 |
| End Cash | $36 | $41 | $89 | $48 |
| Free Cash Flow | -$32 | -$97 | -$112 | -$87 |